Recurrence rates for sole therapy with imiquimod (9%-19%) are substantially lower than for most other genital wart
treatments, including podophyllotoxin.
health agency also said two HPV types -- 16 and 18 -- cause 70 percent of cervical cancer and precancerous cervical lesions, while non-cancer causing types of HPV, especially types 6 and 11, can cause genital warts
and respiratory papillomatosis.
Several investigations have been performed on the quality of life (QoL) in genital wart
Viral wart, genital wart
, autoinoculation, recalcitrant.
Objective: To evaluate the therapeutic effects of combined 5-aminolevulinic acid (ALA) and photodynamic therapy (PDT) on genital warts
and the safety.
The 2 types that cause 90% of genital warts
are called HPV 6 and HPV 11.
In analyses controlling for demographic characteristics, sexual risk factors and STD history, male condom users were more likely than nonusers to have genital warts
(odds ratio, 1.
are the commonest sexual infection in the UK.
can be caused by various types of human papillomavirus (HPV), but they are not the same as those that cause warts on the hands and feet.
Did you know that genital warts
are more likely to affect women than men?
RECEIVING TWO DOSES of human papillomavirus (HPV) vaccine at 5-month intervals or longer appears to provide similar protection against genital warts
as three doses among girls initiating the series before age 15 years, reported Rebecca B.
Merck , known as MSD outside of the United States and Canada, announced today that in a systematic review conducted of the global impact and effectiveness of GARDASIL Human Papillomavirus Quadrivalent Vaccine, Recombinant , substantial reductions were observed in HPV 6/11/16/18-related infection, genital warts
, Pap abnormalities and cervical pre-cancers.
accounted for the highest number of cases in males (35.
Many treatment options (topical, systemic, or surgical) can be used for genital warts
, but there has been no single specific and satisfying therapy [3-5].
USPRwire, Fri Aug 07 2015] GlobalData's clinical trial report, "Genital Warts
(Condylomata Acuminata) Global Clinical Trials Review, H1, 2015" provides data on the Genital Warts
(Condylomata Acuminata) clinical trial scenario.